Rossmore Private Capital’s GSK GSK Stock Holding History

Rossmore Private Capital’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$239K	Hold	4,518	–	–	0.02%	282
2026 Q1	$252K	Hold	4,518	–	–	0.02%	267
2025 Q4	$223K	Buy	+4,518	New	+$211K	0.02%	272
2022 Q3	–	Sell	-3,785	Closed	-$206K	–	224
2022 Q2	$206K	Buy	+3,785	New	+$209K	0.04%	218
2018 Q1	–	Sell	-176	Closed	-$7.8K	–	233
2017 Q4	$7.8K	Buy	+176	New	+$8.13K	0.01%	323

Other funds holding GSK

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

MHI

Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

TNB

Thomasville National Bank Thomasville, Georgia $1.82B AUM

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

FVWA

Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return

Rossmore Private Capital's GSK Position: Q2 2026 in Review

Rossmore Private Capital held its GSK (GSK) position steady in Q2 2026 at 4,518 shares worth $239K. The position accounts for 0.02% of the portfolio, ranked #282.

Rossmore Private Capital first reported a position in GSK in Q4 2017 and has held it in 5 quarters since. The position peaked at $252K in Q1 2026. 439 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Rossmore Private Capital held 4,518 shares of GSK worth $239K as of Q2 2026.
Rossmore Private Capital left its GSK share count unchanged in Q2 2026.
GSK made up 0.02% of Rossmore Private Capital's portfolio in Q2 2026, its #282 holding.
Rossmore Private Capital first reported a position in GSK in Q4 2017 and has held it in 5 quarters since.
Rossmore Private Capital's GSK position peaked at $252K in Q1 2026.
439 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Rossmore Private Capital's 13F filing for Q2 2026, filed 31 Jul 2026.